Calmodulin 3 antibody

Catalog No. ABIN7112206

Product Details anti-Calmodulin 3 Antibody

Target: Calmodulin 3 (CALM3) (Calmodulin 3 (Phosphorylase Kinase, Delta) (CALM3))

Reactivity: Human, Rat, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Calmodulin 3 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Purification: Immunogen affinity purified

Purity: ≥95 % as determined by SDS-PAGE

Immunogen: calmodulin 3(phosphorylase kinase, delta)

Isotype: IgG

Application Details

Application Notes: WB: 1:500-1:2000, IHC: 1:20-1:200

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Expiry Date: 12 months

Target Details for Calmodulin 3

Target: Calmodulin 3 (CALM3) (Calmodulin 3 (Phosphorylase Kinase, Delta) (CALM3))

Alternative Name: CALM3 (CALM3 Products)

Synonyms: PHKD antibody, PHKD3 antibody, CaMA antibody, R75142 antibody, RNCAMIII antibody, calmodulin 3 antibody, CALM3 antibody, Calm3 antibody

Background: Synonyms:CALML2, CAM3, CAMC, CAMIII Background:Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis.

Molecular Weight: 17 kDa

Gene ID: 808

UniProt: P62158

Pathways: RTK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cellular Glucan Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Phototransduction, Negative Regulation of Transporter Activity, VEGFR1 Specific Signals, BCR Signaling